Jazz Pharmaceuticals Insider Sold Shares Worth $1,381,980, According to a Recent SEC Filing

MT newswire2026/10/05 20:25

04:25 PM EDT, 10/05/2026 (MT Newswires) -- Bruce C Cozadd, Director, on October 01, 2026, sold 6,000 shares in Jazz Pharmaceuticals (JAZZ) for $1,381,980. Following the Form 4 filing with the SEC, Cozadd has control over a total of 345,875 ordinary shares of the company, with 345,875 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1232524/000119321026000028/xslF345X05/edgardoc.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

The value of cryptocurrency assets held by the U.S. government has shrunk by $16 billion from last year’s peak.

AiCoin•2026/10/11 03:23

Copper prices approach historic highs! UBS remains bullish: "Still most optimistic"

华尔街见闻•2026/10/11 01:57

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year

BeInCrypto•2026/10/10 22:48

The number of stablecoin holders on the Solana chain has surpassed 14 million.

AiCoin•2026/10/10 21:35